190 related articles for article (PubMed ID: 35382253)
1. Hematopoietic stem cell transplantation in systemic sclerosis: Yes!! BUT. .
AlOdhaibi KA; Varga J; Furst DE
J Scleroderma Relat Disord; 2021 Feb; 6(1):44-49. PubMed ID: 35382253
[TBL] [Abstract][Full Text] [Related]
2. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D
Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011
[TBL] [Abstract][Full Text] [Related]
3. Autologous hematopoietic stem cell transplantation for systemic sclerosis.
Milanetti F; Bucha J; Testori A; Burt RK
Curr Stem Cell Res Ther; 2011 Mar; 6(1):16-28. PubMed ID: 20955159
[TBL] [Abstract][Full Text] [Related]
4. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.
Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R
Haematologica; 2010 Feb; 95(2):284-92. PubMed ID: 19773265
[TBL] [Abstract][Full Text] [Related]
5. Stem cell transplantation in systemic sclerosis.
van Laar JM; Sullivan K
Curr Opin Rheumatol; 2013 Nov; 25(6):719-25. PubMed ID: 24047607
[TBL] [Abstract][Full Text] [Related]
6. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol.
Spierings J; van Rhenen A; Welsing PM; Marijnissen AC; De Langhe E; Del Papa N; Dierickx D; Gheorghe KR; Henes J; Hesselstrand R; Kerre T; Ljungman P; van de Loosdrecht AA; Marijt EW; Mayer M; Schmalzing M; Schroers R; Smith V; Voll RE; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Walker UA; Wuttge DM; van Laar JM
BMJ Open; 2021 Mar; 11(3):e044483. PubMed ID: 33737437
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up.
Pawlak-Buś K; Schmidt W; Olejarz M; Czyż A; Komarnicki M; Leszczyński P
Reumatologia; 2019; 57(1):50-54. PubMed ID: 30858631
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluating inclusion criteria for autologous hematopoietic stem cell transplantation in advanced systemic sclerosis: Three successful cases and review of the literature.
Shah A; Spierings J; van Laar JM; Sullivan KM
J Scleroderma Relat Disord; 2021 Jun; 6(2):199-205. PubMed ID: 35386745
[TBL] [Abstract][Full Text] [Related]
10. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
[TBL] [Abstract][Full Text] [Related]
11. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
12. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
13. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
Burt RK; Traynor AE; Pope R; Schroeder J; Cohen B; Karlin KH; Lobeck L; Goolsby C; Rowlings P; Davis FA; Stefoski D; Terry C; Keever-Taylor C; Rosen S; Vesole D; Fishman M; Brush M; Mujias S; Villa M; Burns WH
Blood; 1998 Nov; 92(10):3505-14. PubMed ID: 9808541
[TBL] [Abstract][Full Text] [Related]
14. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
van Laar JM; Farge D; Sont JK; Naraghi K; Marjanovic Z; Larghero J; Schuerwegh AJ; Marijt EW; Vonk MC; Schattenberg AV; Matucci-Cerinic M; Voskuyl AE; van de Loosdrecht AA; Daikeler T; Kötter I; Schmalzing M; Martin T; Lioure B; Weiner SM; Kreuter A; Deligny C; Durand JM; Emery P; Machold KP; Sarrot-Reynauld F; Warnatz K; Adoue DF; Constans J; Tony HP; Del Papa N; Fassas A; Himsel A; Launay D; Lo Monaco A; Philippe P; Quéré I; Rich É; Westhovens R; Griffiths B; Saccardi R; van den Hoogen FH; Fibbe WE; Socié G; Gratwohl A; Tyndall A;
JAMA; 2014 Jun; 311(24):2490-8. PubMed ID: 25058083
[TBL] [Abstract][Full Text] [Related]
15. High-dose immunosuppression and autologous hematopoietic stem cell rescue for severe multiple sclerosis.
Fassas A; Kazis A
J Hematother Stem Cell Res; 2003 Dec; 12(6):701-11. PubMed ID: 14977479
[TBL] [Abstract][Full Text] [Related]
16. Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society.
Miller AE; Chitnis T; Cohen BA; Costello K; Sicotte NL; Stacom R;
JAMA Neurol; 2021 Feb; 78(2):241-246. PubMed ID: 33104165
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
[TBL] [Abstract][Full Text] [Related]
18. Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.
Curro' D; Vuolo L; Gualandi F; Bacigalupo A; Roccatagliata L; Capello E; Uccelli A; Saccardi R; Sormani MP; Mancardi G
Mult Scler; 2015 Oct; 21(11):1423-30. PubMed ID: 25583838
[TBL] [Abstract][Full Text] [Related]
19. Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?
Atkins HL; Muraro PA; van Laar JM; Pavletic SZ
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S177-83. PubMed ID: 22226104
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
